MedPath

Evalution the effect of nanobioglass and diode laser (980 nm) in dentin hypersensitivity treatment

Phase 2
Recruiting
Conditions
dentin hypersensivity.
Other specified diseases of hard tissues of teeth
K03.89
Registration Number
IRCT20240109060667N1
Lead Sponsor
Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
15
Inclusion Criteria

Good general health No known allergy to commercial dental products
Teeth studied have no decay or repair
The patient has not previously received treatment for their dentinal allergy.
The patient should be able to determine the pain score in VAS in terms of age and mentality.
Patients should not have a history of receiving bleaching treatments by bleaching method.

Exclusion Criteria

People with chronic diseases with episodes of daily pain who have taken anticonvulsants? analgesics ? antihistamines ? sedatives ? anti-inflammatory or analgesic drugs in the past 72 hours.
People who have used toothpaste or hypoallergenic mouthwashes in the past 3 months.
People who have had periodontal surgery in the past 6 months.
White bread teeth or white teeth that have cracks, previous repairs, caries lesions or active periodontal disease. Subjects with periodontal recession will remain active in the study.
People with deep cavities in the vicinity of sensitive teeth are likely to be mistaken for sensitive tooth pain.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
People whose VAS scores are above 5. Timepoint: Patients were called for followup after 1 week, 1 month and 6 months after treatment. At each visit, the mentioned evaluation process was repeated for each patient and VAS score was recorded. Method of measurement: The lowest score is zero which means the situation is completely painless, and the highest score is 10, which means the maximum amount of pain that a person can experience.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath